LOCOMMOTION: analysis of SOC for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:17 3 years ago 61 Далее Скачать
Key findings of the LocoMMotion study VJHemOnc – Video Journal of Hematology & HemOnc 1:41 2 years ago 50 Далее Скачать
Comparison of patient-reported outcomes from CARTITUDE-1 and LocoMMotion VJHemOnc – Video Journal of Hematology & HemOnc 2:15 2 years ago 43 Далее Скачать
Subgroup Analyses in RRMM Patients Receiving Real-Life Standard of Care in the LocoMMotion Study International Myeloma Foundation 4:36 2 years ago 128 Далее Скачать
Ixazomib-based therapy for R/R myeloma in the real-world setting VJHemOnc – Video Journal of Hematology & HemOnc 5:45 4 years ago 108 Далее Скачать
Genomic and transcriptomic analysis of R/R myeloma in the Phase III BELLINI study VJHemOnc – Video Journal of Hematology & HemOnc 3:31 4 years ago 30 Далее Скачать
LocoMMotion: A multinational study of real-life current standards of care in pts with RRMM International Myeloma Foundation 3:27 3 years ago 293 Далее Скачать
Updates from the LINKER-MM1 study: linvoseltamab in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:33 1 year ago 129 Далее Скачать
Targeted therapies in R/R myeloma: novel approaches being explored VJHemOnc – Video Journal of Hematology & HemOnc 1:18 3 months ago 40 Далее Скачать
Dr Lentzsch on Results for Linvoseltamab in Heavily Pretreated R/R Myeloma OncLive 1:23 5 months ago 51 Далее Скачать
Clinical benefit of teclistamab vs real-world physician’s choice for R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:14 1 year ago 314 Далее Скачать
IV daratumumab in R/R myeloma: bodyweight analysis VJHemOnc – Video Journal of Hematology & HemOnc 3:56 4 years ago 58 Далее Скачать
Subgroup analyses of CASTOR & POLLUX in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:50 2 years ago 39 Далее Скачать
Iberdomide with dexamethasone for R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:40 5 years ago 577 Далее Скачать
MRD negativity rates following carfilzomib, dex & dara in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:34 4 years ago 107 Далее Скачать
Real-world safety & efficacy of isatuximab-pomalidomide-dexamethasone in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:45 2 years ago 89 Далее Скачать
Updated CASTOR analysis: daratumumab plus Vd for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:21 6 years ago 525 Далее Скачать
Apollo: pomalidomide plus dexamethasone, with/without daratumumab in R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 1:42 4 years ago 215 Далее Скачать
Selecting a therapeutic approach for patients with relapsed/refractory myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:06 2 months ago 32 Далее Скачать
ARROW: carfilzomib dosing in frail R/R multiple myeloma patients VJHemOnc – Video Journal of Hematology & HemOnc 2:19 5 years ago 118 Далее Скачать
